SIGNPATH PHARMA, INC. Derivative, Loss on Derivative
SIGNPATH PHARMA, INC. reported Derivative, Loss on Derivative of $3.92 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:DerivativeLossOnDerivative · last filed 2014-03-31
- SIGNPATH PHARMA, INC. derivative, loss on derivative for the quarter ending 2013-12-31 was $5.70M.
- SIGNPATH PHARMA, INC. derivative, loss on derivative for the quarter ending 2013-09-30 was -$5.00M.
- SIGNPATH PHARMA, INC. derivative, loss on derivative for the quarter ending 2013-06-30 was -$310.27K.
- SIGNPATH PHARMA, INC. derivative, loss on derivative for the quarter ending 2013-03-31 was -$377.53K.
- SIGNPATH PHARMA, INC. derivative, loss on derivative for fiscal 2013 was $3.92K, a 51.89% decline from fiscal 2012.
- SIGNPATH PHARMA, INC. derivative, loss on derivative for fiscal 2012 was $8.15K, a 96.67% decline from fiscal 2011.
- SIGNPATH PHARMA, INC. derivative, loss on derivative for fiscal 2011 was $245.09K, a 54.45% decline from fiscal 2010.
- SIGNPATH PHARMA, INC. derivative, loss on derivative for fiscal 2010 was $538.01K.
| Period end | Derivative, Loss on Derivative 3 month | Derivative, Loss on Derivative 6 month | Derivative, Loss on Derivative 9 month | Derivative, Loss on Derivative 12 month |
|---|---|---|---|---|
| 2013-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $691.72K derived: sum of 2 quarters · filed 2014-03-31 | $381.45K derived: sum of 3 quarters · filed 2014-03-31 | $3.92K 10-K · filed 2014-03-31 |
| 2013-09-30 | -$5.00M derived: 10-K 12 month − 3 quarters · filed 2014-03-31 | -$5.31M derived: sum of 2 quarters · filed 2014-03-31 | -$5.69M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$310.27K 10-Q · filed 2013-08-14 | -$687.80K derived: sum of 2 quarters · filed 2013-08-14 | ||
| 2013-03-31 | -$377.53K 10-Q · filed 2013-05-15 | |||
| 2012-12-31 | $8.15K 10-K · filed 2013-04-01 | |||
| 2011-12-31 | $245.09K 10-K · filed 2013-04-01 | |||
| 2010-12-31 | $538.01K 10-K · filed 2013-04-01 |